Diabetic retinopathy and public health

Automated Image Detection of Retinal Pathology

Volumn , Issue , 2009, Pages 27-66

  Worsley, David ^a   Simmons, David ^b  

^a Health Waikato   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84945263241     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (145)

1. Fong, D.S., Aiello, L.P., and Gardner, Retinopathy in diabetes, Diabetes Care, 27(suppl 1), S84, 2004.
2. Zimmet, P., Alberti, K.G., and Shaw, J., Global and societal implications of the diabetes epidemic, Nature, 414, 782, 2001.
3. New Zealand Herald, World faces diabetes catastrophe, experts say, New Zealand Herald, August 26, 2003.
4. Stumvoll, M., Goldstein, B.J., and van Haeften, T.W., Type 2 diabetes: Principles of pathogensis and therapy, Lancet, 365, 1333, 2005.
5. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., et al., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med., 346, 393, 2002.
6. Tuomilehto, J., Lindstrom, J., Eriksson, J.G., et al., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med., 344, 1343, 2001.
7. Ramachandran, A., Snehalatha, C., Mary, S., et al., The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1), Diabetologia, 49, 289, 2006.
8. Daneman, D., Type 1 diabetes, Lancet, 367, 847, 2006.
9. Permutt, M.A., Wasson, J., and N., C., Genetic epidemiology of diabetes, J Clin Invest, 115, 1431, 2005.
10. Fagot-Campagna, A., Pettitt, D.J., Engelgau, M.M., et al., Type 2 diabetes among North American children and adolescents: An epidemiologic review and a public health perspective, J. Pediatr., 136, 664, 2000.
11. Rosenbloom, A., Joe, J.R., Young, R.S., et al., Emerging epidemic of type 2 diabetes in youth, Diabetes Care, 22, 345, 1999.
12. McElduff, A., Ross, G.P., Lagström, J.A., et al., Pregestational diabetes and pregnancy: An Australian experience, Diabetes Care, 28, 1260, 2005.
13. Pettitt, D.J., Bennett, P.H., Knowler, W.C., et al., Gestational diabetes mellitus and impaired glucose tolerance during pregnancy: Long terms effects on obesity and glucose tolerance in the offspring, Diabetes, 34(supp 2), 119, 1985.
14. Amos, A.F., McCarty, D.J., and Zimmet, P., The rising global burden of diabetes and its complications: Estimates and projections to the year 2010, Diab Med, 14(supp 5), S1, 1997.
15. International Diabetes Federation, ed., Diabetes Atlas, International Diabetes Federation, 2nd ed., 2003.
16. Dorf, A. and et al., Retinopathy in Pima Indians: Relationship to glucose level, duration of diabetes and age at examination in a population with a high prevalence of diabetes, Diabetes, 25, 554, 1976.
17. Harris, M., Klein, R., Welborn, T., et al., Onset of NIDDM occurs at least 4–7 years before clinical diagnosis, Diabetes Care, 15, 815, 1992.
18. Tapp, R.J., Shaw, J.E., Harper, C.A., et al., The prevalence of and factors associated with diabetic retinopathy in the Australian population, Diabetes Care, 26, 1731, 2003.
19. Yu, T., Mitchell, P., Berry, G., et al., Retinopathy in older persons without diabetes and its relationship to hypertension, Arch Ophthalmol, 116, 83, 1998.
20. Aiello, L.P., Cahill, M.T., and Wong, J.S., Systemic considerations in the management of diabetic retinopathy, Am J Ophthalmol, 132, 760, 2001.
21. Klein, R., Klein, B.E., Moss, S.E., et al., The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema, Ophthalmology, 91, 1464, 1985.
22. Williams, R., Airey, M., Baxter, H., et al., Epidemiology of diabetic retinopathy and macular oedema: A systematic review, Eye, 18, 963, 2004.
23. Simmons, D., Clover, G., and Hope, C., Ethnic differences in diabetic retinopathy, Diabet Med, 24, 1093, 2007.
24. Frank, R.N., Diabetic retinopathy, N Engl J Med, 350, 48, 2004.
25. Early Treatment Diabetic Retinopathy Study Research Group, Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified Airlie House classification. ETDRS report number 10., Ophthalmology, 98, 786, 1991.
26. Klein, R., Barriers to prevention of vision loss caused by diabetic retinopathy, Arch Ophthalmol, 115, 1073, 1997.
27. American Academy of Ophthalmology, Diabetic retinopathy disease severity scale 2002, 2002, http://www.aao.org/education/library/recommendations/international dr.cfm.
28. Klein, R., Klein, B.E., Moss, S.E., et al., The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes, Ophthalmology, 105, 1801, 1998.
29. Klein, R., Klein, B.E., and Moss, S.E., How many steps of progression of diabetic retinopathy are meaningful? The Wisconsin Epidemiologic Study of Diabetic Retinopathy, Arch Ophthalmol, 119, 547, 2001.
30. Klein, R., Klein, B.E., Moss, S.E., et al., The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years, Arch Ophthalmol, 102, 527, 1984.
31. Yanko, L., Goldbourt, U., Michaelson, I.C., et al., Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men, Br J Ophthalmol, 67, 759, 1984.
32. Diabetic Retinopathy Vitrectomy Study, Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5, Arch Ophthalmol, 108, 958, 1990.
33. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 1993.
34. Diabetes Control and Complications Trial Research Group, Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial, Ophthalmology, 102, 647, 1995.
35. UK Prospective Diabetes Study (UKPDS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 1998.
36. Klein, R., Klein, B.E., Lee, K.E., et al., The incidence of hypertension in insulin-dependent diabetes, Arch Intern Med, 156, 622, 1996.
37. Klein, R., Klein, B.E., Moss, S.E., et al., Blood pressure and hypertension in diabetes, Am J Epidemiol, 122, 75, 1985.
38. UK Prospective Diabetes Study (UKPDS) Group, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38, BMJ, 317, 703, 1998.
39. Park, J.Y., Kim, H.K., Chung, Y.E., et al., Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes, Diabetes Care, 21, 530, 1998.
40. Hasslacher, C., Bostedt-Kiesel, A., Kempe, H.P., et al., Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients, Diabetologia, 36, 1051, 1993.
41. Klein, R., Moss, S.E., and Klein, B.E., Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? Ophthalmology, 100, 1140, 1993.
42. Klein, R., Klein, B.E., Moss, S.E., et al., The 10-year incidence of renal insufficiency in people with type 1 diabetes, Diabetes Care, 22, 743, 1999.
43. Lloyd, G., The importance of accuracy in blood pressure recording, Br J Clin Pract, 49, 284, 1996.
44. UK Prospective Diabetes Study Group (UKPDS) X. Urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyc-eridaemia, Diabetologia, 36, 1021, 1993.
45. Moloney, J.B. and Drury, M.I., The effect of pregnancy on the natural course of diabetic retinopathy, Am J Ophthalmol, 93, 745, 1982.
46. Klein, B.E., Moss, S.E., and Klein, R., Effect of pregnancy on progression of diabetic retinopathy, Diabetes Care, 13, 34, 1990.
47. Diabetes Control and Complications Trial (DCCT) Research Group, Effect of pregnancy on microvascular complications in the Diabetes Control and Complications Trial, Diabetes Care, 23, 1084, 2000.
48. Sone, H., Okuda, Y., Kawakami, Y., et al., Progesterone induces vascular endothelial growth factor on retinal pigment epithelial cells in culture, Life Sci, 59, 21, 1996.
49. Chen, H.C., Newsom, R.S., Patel, V., et al., Retinal blood flow changes during pregnancy in women with diabetes, Invest Ophthalmol Vis Sci, 35, 3199, 1994.
50. Schocket, L.S., Grunwald, J.E., Tsang, A.F., et al., The effect of pregnancy on retinal hemodynamics in diabetic versus nondiabetic mothers, Am J Ophthalmol, 128, 477, 1999.
51. Muhlhauser, I., Cigarette smoking and diabetes: An update, Diabet Med, 11, 336, 1994.
52. Sawicki, P.T., Muhlhauser, I., Bender, R., et al., Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy, J Intern Med, 239, 345, 1996.
53. Mohr, S.E. and Boswell, R.E., Genetic analysis of Drosophila melanogaster polytene chromosome region 44D–45F: Loci required for viability and fertility, Genetics, 160, 1503, 2002.
54. Barber, A.J., Lieth, E., Khin, S.A., et al., Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin, J Clin Invest, 102, 783, 1998.
55. Ciulla, T.A., Harris, A., Latkany, P., et al., Ocular perfusion abnormalities in diabetes, Acta Ophthalmol Scand, 80, 468, 2002.
56. Otani, T., Kishi, S., and Maruyama, Y., Patterns of diabetic macular edema with optical coherence tomography, Am J Ophthalmol, 127, 688, 1999.
57. Gabbay, K.H., Hyperglycemia, polyol metabolism, and complications of diabetes mellitus, Annu Rev Med, 26, 521, 1975.
58. Sato, S., Secchi, E.F., Lizak, M.J., et al., Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells, Invest Ophthalmol Vis Sci, 40, 697, 1999.
59. Brownlee, M., Vlassara, H., and Cerami, A., Nonenzymatic glycosylation and the pathogenesis of diabetic complications, Ann Intern Med, 101, 527, 1984.
60. Friedman, E.A., Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications, Diabetes Care, 22 Suppl 2, B65, 1999.
61. Schmidt, A.M., Yan, S.D., Wautier, J.L., et al., Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis, Circ Res, 84, 489, 1999.
62. Singh, R., Barden, A., Mori, T., et al., Advanced glycation end-products: A review, Diabetologia, 44, 129, 2001.
63. Inoguchi, T., Battan, R., Handler, E., et al., Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation, Proc Natl Acad Sci USA, 89, 11059, 1992.
64. Xia, P., Inoguchi, T., Kern, T.S., et al., Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia, Diabetes, 43, 1122, 1994.
65. Nishikawa, T., Edelstein, D., and Brownlee, M., The missing link: A single unifying mechanism for diabetic complications, Kidney Int Suppl, 77, S26, 2001.
66. Taher, M.M., Garcia, J.G., and Natarajan, V., Hydroperoxide-induced diacylglycerol formation and protein kinase C activation in vascular endothelial cells, Arch Biochem Biophys, 303, 260, 1993.
67. Nagpala, P.G., Malik, A.B., Vuong, P.T., et al., Protein kinase C beta 1 overex-pression augments phorbol ester-induced increase in endothelial permeability, J Cell Physiol, 166, 249, 1996.
68. Xia, P., Aiello, L.P., Ishii, H., et al., Characterization of vascular endothelial growth factor’s effect on the activation of protein kinase C, its isoforms, and endothelial cell growth, J Clin Invest, 98, 2018, 1997.
69. Giugliano, D., Ceriello, A., and Paolisso, G., Oxidative stress and diabetic vascular complications, Diabetes Care, 19, 257, 1996.
70. Sakata, K., Funatsu, H., Harino, S., et al., Relationship between macular microcirculation and progression of diabetic macular edema, Ophthalmology, 113, 1385, 2006.
71. McMillan, D.E., Plasma protein changes, blood viscosity, and diabetic microangiopathy, Diabetes, 25, 858, 1976.
72. McMillan, D.E., Utterback, N.G., and La Puma, J., Reduced erythrocyte deformability in diabetes, Diabetes, 27, 895, 1978.
73. Schmid-Schonbein, H. and Volger, E., Red-cell aggregation and red-cell deformability in diabetes, Diabetes, 25, 897, 1976.
74. Sagel, J., Colwell, J.A., Crook, L., et al., Increased platelet aggregation in early diabetus mellitus, Ann Intern Med, 82, 733, 1975.
75. Miyamoto, K. and Ogura, Y., Pathogenetic potential of leukocytes in diabetic retinopathy, Semin Ophthalmol, 14, 233, 2000.
76. Grant, M.B., Afzal, A., Spoerri, P., et al., The role of growth factors in the pathogenesis of diabetic retinopathy, Expert Opin Investig Drugs, 13, 1275, 2004.
77. Joussen, A.M., Poulaki, V., Qin, W., et al., Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo, Am J Pathol, 160, 501, 2002.
78. Miller, J.W., Adamis, A.P., and Aiello, L.P., Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy, Diabetes Metab Rev, 13, 37, 1997.
79. Aiello, L.P., Avery, R.L., Arrigg, P.G., et al., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders, N Engl J Med, 331, 1480, 1994.
80. Cunha-Vaz, J., Faria de Abreu, J.R., and Campos, A.J., Early breakdown of the blood-retinal barrier in diabetes, Br J Ophthalmol, 59, 649, 1975.
81. Diabetes Control and Complications Trial (DCCT), Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial, Arch Ophthalmol, 116, 874, 1998.
82. Diabetic Retinopathy Study Research Group, Preliminary report on effects of photocoagulation therapy, Am J Ophthalmol, 81, 383, 1976.
83. Sjolie, A.K. and Moller, F., Medical management of diabetic retinopathy, Diabet Med, 21, 666, 2004.
84. Diabetic Retinopathy Study Research Group, Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8, Ophthalmol, 88, 583, 1981.
85. Diabetic Retinopathy Study Research Group, Four risk factors for severe visual loss in diabetic retinopathy. the third report from the Diabetic Retinopathy Study, Arch Ophthalmol, 97, 654, 1979.
86. Aiello, L.M., Perspectives on diabetic retinopathy, Am J Ophthalmol, 136, 122, 2003.
87. Fong, D.S., Strauber, S.F., Aiello, L.P., et al., Comparison of the modified early treatment diabetic retinopathy study and mild macular grid laser photocoagulation strategies for diabetic macular edema, Arch Ophthalmol, 125, 469, 2007.
88. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group, Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 1, Arch Ophthalmol, 103, 1796, 1985.
89. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group, Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9, Ophthalmol, 98(5 Suppl), 766, 1991.
90. Luttrull, J.K., Musch, D.C., and Spink, C.A., Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy, Eye, 22, 607, 2008.
91. Luttrull, J.K., Musch, D.C., and Mainster, M.A., Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema, Br J Ophthalmol, 89, 74, 2004.
92. The Diabetic Retinopathy Vitrectomy Study Research Group, Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study Report 2, Arch Ophthalmol, 103, 1644, 1985.
93. The Diabetic Retinopathy Vitrectomy Study Research Group, Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial—Diabetic Retinopathy Vitrectomy Study Report 4, Ophthalmol, 95, 1321, 1988.
94. Smiddy, W.E. and Flynn, H.W., Vitrectomy in the management of diabetic retinopathy, Surv Ophthalmol, 43, 491, 1999.
95. Sakuraba, T., Suzuki, Y., Mizutani, H., et al., Visual improvement after removal of submacular exudates in patients with diabetic maculopathy, Ophthalmic Surg Lasers, 31, 287, 2000.
96. Takaya, K., Suzuki, Y., Mizutani, H., et al., Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy, Retina, 24, 23, 2004.
97. Wada, M., Ogata, N., Minamino, K., et al., Trans-tenon’s retrobulbar injection of triamcinolone acetonide for diffuse diabetic macular edema, Jpn J Ophthalmol, 49, 509, 2005.
98. Bakri, S.J. and Kaiser, P.K., Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema, Am J Ophthalmol, 139, 290, 2005.
99. Gillies, M.C., Sutter, F.K., Simpson, J.M., et al., Intravitreal triamcinolone for refractory diabetic macular edema: Two-year results of a double-masked, placebo-controlled, randomized clinical trial, Ophthalmology, 113, 1533, 2006.
100. Martidis, A., Duker, J.S., Greenberg, P.B., et al., Intravitreal triamcinolone for refractory diabetic macular edema, Ophthalmology, 109, 920, 2002.
101. Massin, P., Audren, F., Haouchine, B., et al., Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: Preliminary results of a prospective controlled trial, Ophthalmology, 111, 218, 2004.
102. Nguyen, Q.D., Tatlipinar, S., Shah, S.M., et al., Vascular endothelial growth factor is a critical stimulus for diabetic macular edema, Am J Ophthalmol, 142, 961, 2006.
103. Chun, D.W., Heier, J.S., Topping, T.M., et al., A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema, Ophthalmology, 113, 1706, 2006.
104. Adamis, A.P., Altaweel, M., Aiello, L.P., et al., A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema, Ophthalmol, 112, 1747, 2005.
105. Krzystolik, M.G., Filippopoulos, T., Ducharme, J.F., et al., Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy, Arch Ophthalmol, 124, 920, 2006.
106. Silva Paula, J., Jorge, R., Alves Costa, R., et al., Short-term results of intravitreal bevacizumab (avastin) on anterior segment neovascularization in neovascular glaucoma, Acta Ophthalmol Scand, 84, 556, 2006.
107. Comer, G.M. and Ciulla, T.A., Pharmacotherapy for diabetic retinopathy, Curr Opin Ophthalmol, 15, 508, 2004.
108. Aiello, L.P., Clermont, A., Arora, V., et al., Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients, Invest Ophthalmol Vis Sci, 47, 86, 2005.
109. Aiello, L.P., Davis, M.D., Girach, A., et al., Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy, Ophthalmology, 113, 2221, 2006.
110. PKC-DMES Study Group, Effect of ruboxistaurin in patients with diabetic macular edema: Thirty-month results of the randomized PKC-DMES clinical trial, Arch Ophthalmol, 125, 318, 2007.
111. Kuppermann, B.D., Thomas, E.L., de Smet, M.D., et al., Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (vitrase) for the management of vitreous hemorrhage, Am J Ophthalmol, 140, 573, 2005.
112. Kuppermann, B.D., Thomas, E.L., de Smet, M.D., et al., Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (vitrase) for the management of vitreous hemorrhage, Am J Ophthalmol, 140, 585, 2005.
113. Williams, J.G., Trese, M.T., Williams, G.A., et al., Autologous plasmin enzyme in the surgical management of diabetic retinopathy, Ophthalmology, 108, 1902, 2001.
114. Trese, M.T., Enzymatic-assisted vitrectomy, Eye, 16, 365, 2002.
115. Kristinsson, J.K., Stefansson, E., Jonasson, F., et al., Systematic screening for diabetic eye disease in insulin dependent diabetes, Acta Ophthalmol, 72, 72, 1994.
116. Singer, D.E., Nathan, D.M., Fogel, H.A., et al., Screening for diabetic retinopathy, Ann Intern Med, 116, 660, 1992.
117. Taylor, R. and British Diabetic Association Mobile Retinal Screening Group, Practical community screening for diabetic retinopathy using the mobile retinal camera: Report of a 12 centre study, Diabet Med, 13, 946, 1996.
118. Williams, G.A., Scott, I.U., Haller, J.A., et al., Single-field fundus photography for diabetic retinopathy screening: A report by the American Academy of Ophthalmology, Ophthalmology, 111, 1055, 2004.
119. Aldington, S.J., Kohner, E.M., Meuer, S., et al., Methodology for retinal photography and assessment of diabetic retinopathy: The Eurodiab IDDM Complications Study, Diabetologia, 38, 437, 1995.
120. Shiba, T., Yamamoto, T., Seki, U., et al., Screening and follow-up of diabetic retinopathy using a new mosaic 9-field fundus photography system, Diabetes Res Clin Pract, 55, 49, 2001.
121. Newsom, R., Moate, B., and Casswell, T., Screening for diabetic retinopathy using digital colour photography and oral fluorescein angiography, Eye, 14, 579, 2000.
122. Bursell, S.E., Cavallerano, J.D., Cavallerano, A.A., et al., Stereo nonmydriatic digital-video color retinal imaging compared with early treatment diabetic retinopathy study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy, Ophthalmology, 108, 572, 2001.
123. Liesenfeld, B., Kohner, E., Piehlmeier, W., et al., A telemedical approach to the screening of diabetic retinopathy: Digital fundus photography, Diabetes Care, 23, 345, 2000.
124. Pugh, J.A., Jacobson, J.M., van Heuven, W.A., et al., Screening for diabetic retinopathy. The wide-angle retinal camera, Diabetes Care, 16, 889, 1993.
125. Fransen, S.R., Leonard-Martin, T.C., Feuer, W.J., et al., Clinical evaluation of patients with diabetic retinopathy: Accuracy of the inoveon diabetic retinopathy-3DT system, Ophthalmology, 109, 595, 2002.
126. Scanlon, P., Screening for diabetic retinopathy in Europe: 15 years after the Saint Vincent Declaration, in Proceedings of the Liverpool Declaration, S.P. Harding, ed., Liverpool, UK, 2005.
127. Bjorvig, S., Johansen, M.A., and Fossen, K., An economic analysis of screening for diabetic retinopathy, J Telemed Telecare, 8, 32, 2002.
128. Cook, H.L., Heacock, G.L., Stanford, M.R., et al., Detection of retinal lesions after telemedicine transmission of digital images, Eye, 14 (Pt 4), 563, 2000.
129. Gomez-Ulla, F., Fernandez, M.I., Gonzalez, F., et al., Digital retinal images and teleophthalmology for detecting and grading diabetic retinopathy, Diabetes Care, 25, 1384, 2002.
130. Moss, S.E., Klein, R., Kessler, S.D., et al., Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy, Ophthalmology, 92, 62, 1985.
131. Owens, D.R., Gibbins, R.L., Lewis, P.A., et al., Screening for diabetic retinopathy by general practitioners: Ophthalmoscopy or retinal photography as 35 mm colour transparencies? Diabet Med, 15, 170, 1998.
132. Sussman, E.J., Tsiaras, W.G., and Soper, K.A., Diagnosis of diabetic eye disease, JAMA, 247, 3231, 1982.
133. Kinyoun, J.L., Martin, D.C., Fujimoto, W.Y., et al., Ophthalmoscopy versus fundus photographs for detecting and grading diabetic retinopathy, Invest Ophthalmol Vis Sci, 33, 1888, 1992.
134. Harding, S.P., Broadbent, D.M., Neoh, C., et al., Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: The Liverpool Diabetic Eye Study, BMJ, 311, 1131, 1995.
135. World Health Organisation, Diabetes care and research in Europe: The St. Vincent Declaration. Diabetes mellitus in Europe: A problem for all ages in all countries. A model for prevention and self care, St. Vincent (Italy), 1989.
136. Reda, E., Dunn, P., Straker, C., et al., Screening for diabetic retinopathy using the mobile retinal camera: The Waikato experience, New Zealand Medical Journal, 116(1180), 562, 2003.
137. Jelinek, H.J., Cree, M.J., Worsley, D., et al., An automated microaneurysm detector as a tool for identification of diabetic retinopathy in rural optometric practice, Clin Exp Optom, 89, 299, 2006.
138. Hipwell, J.H., Strachan, F., Olson, J.A., et al., Automated detection of microaneurysms in digital red-free photographs: A diabetic retinopathy screening tool, Diabetic Medicine, 17(8), 588, 2000.
139. Fong, D.S., Aiello, L., Gardner, T.W., et al., Diabetic retinopathy, Diabetes Care, 26, 226, 2002.
140. Batchelder, T.J., Fireman, B., Friedman, G.D., et al., The value of routine dilated pupil screening examination, Arch Ophthalmol, 115, 1179, 1997.
141. Vijan, S., Hofer, T.P., and Hayward, R.A., Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus, JAMA, 283, 889, 2000.
142. James, M., Turner, D.A., Broadbent, D.M., et al., Cost-effectiveness analysis of screening for sight threatening diabetic eye disease, British Medical Journal, 320, 1627, 2000.
143. James, M. and Little, R., Screening for diabetic retinopathy: Report to the National Screening Committee, 2001, http://www.diabetic-retinopathy. screening.nhs.uk/decision-analysis.html.
144. Madden, A.C., Simmons, D., McCarty, C.A., et al., Eye health in rural areas, Clinical and Experimental Ophthalmology, 30, 316, 2002.
145. Simmons, D., Weblemoe, T., Voyle, J., et al., Personal barriers to diabetes care: Lessons from a multiethnic community in New Zealand, Diabet Med, 15, 958, 1998.